{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:03Z","timestamp":1786982223338,"version":"build-2736575974"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12035-024-04486-w","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T10:03:59Z","timestamp":1726653839000},"page":"6898-6912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Is SIRT3 and Mitochondria a Reliable Target for Parkinson\u2019s Disease and Aging? A Narrative Review"],"prefix":"10.1007","volume":"62","author":[{"given":"Amarjith Thiyyar","family":"Kandy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Zubair","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1170-6370","authenticated-orcid":false,"given":"Gomathy","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"4486_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fphar.2012.00016","volume":"3","author":"S Moniot","year":"2012","unstructured":"Moniot S, Weyand M, Steegborn C (2012) Structures, substrates, and regulators of mammalian Sirtuins\u2013opportunities and challenges for drug development. Front Pharmacol 3:16","journal-title":"Front Pharmacol"},{"key":"4486_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13148-016-0224-3","volume":"8","author":"V Carafa","year":"2016","unstructured":"Carafa V, Rotili D, Forgione M et al (2016) Sirtuin functions and modulation: from chemistry to the clinic. Clin Epigenetics 8:61. https:\/\/doi.org\/10.1186\/s13148-016-0224-3","journal-title":"Clin Epigenetics"},{"key":"4486_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbpa.2008.01.019","volume":"12","author":"JC Milne","year":"2008","unstructured":"Milne JC, Denu JM (2008) The Sirtuin family: therapeutic targets to treat diseases of aging. Curr Opin Chem Biol 12:11\u201317","journal-title":"Curr Opin Chem Biol"},{"key":"4486_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jchemneu.2017.11.009","volume":"95","author":"A Khanna","year":"2019","unstructured":"Khanna A, Acharjee P, Acharjee A, Trigun SK (2019) Mitochondrial SIRT3 and neurodegenerative brain disorders. J Chem Neuroanat 95:43\u201353","journal-title":"J Chem Neuroanat"},{"key":"4486_CR5","first-page":"80","volume":"1816","author":"TY Alhazzazi","year":"2011","unstructured":"Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL (2011) SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta BBA-Rev Cancer 1816:80\u201388","journal-title":"Biochim Biophys Acta BBA-Rev Cancer"},{"key":"4486_CR6","doi-asserted-by":"publisher","first-page":"585821","DOI":"10.3389\/fphar.2020.585821","volume":"11","author":"R Manjula","year":"2021","unstructured":"Manjula R, Anuja K, Alcain FJ (2021) SIRT1 and SIRT2 activity control in neurodegenerative diseases. Front Pharmacol 11:585821","journal-title":"Front Pharmacol"},{"issue":"5","key":"4486_CR7","first-page":"53","volume":"25","author":"SW Min","year":"2013","unstructured":"Min SW, Sohn PD, Cho SH, Swanson RA, Gan L (2013) Sirtuins in neurodegenerative diseases: an update on potential mechanisms. Front Aging Neurosci 25(5):53","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"4486_CR8","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/bph.15570","volume":"179","author":"JA Leite","year":"2022","unstructured":"Leite JA, Ghirotto B, Targhetta VP, de Lima J, C\u00e2mara NO (2022) Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders. Br J Pharmacol 179(8):1496\u2013511","journal-title":"Br J Pharmacol"},{"key":"4486_CR9","doi-asserted-by":"publisher","first-page":"614331","DOI":"10.3389\/fnins.2020.614331","volume":"14","author":"P Chandramowlishwaran","year":"2020","unstructured":"Chandramowlishwaran P, Vijay A, Abraham D, Li G, Mwangi SM, Srinivasan S (2020) Role of sirtuins in modulating neurodegeneration of the enteric nervous system and central nervous system. Front Neurosci 14:614331","journal-title":"Front Neurosci"},{"key":"4486_CR10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1107\/S0907444913015448","volume":"69","author":"GTT Nguyen","year":"2013","unstructured":"Nguyen GTT, Schaefer S, Gertz M et al (2013) Structures of human sirtuin 3 complexes with ADP-ribose and with carba-NAD+ and SRT1720: binding details and inhibition mechanism. Acta Crystallogr D Biol Crystallogr 69:1423\u20131432","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"4486_CR11","doi-asserted-by":"publisher","first-page":"e1047","DOI":"10.1038\/cddis.2014.14","volume":"5","author":"Y Chen","year":"2014","unstructured":"Chen Y, Fu LL, Wen X et al (2014) Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis 5:e1047\u2013e1047","journal-title":"Cell Death Dis"},{"issue":"1","key":"4486_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13205-022-03455-1","volume":"13","author":"A Sharma","year":"2023","unstructured":"Sharma A, Mahur P, Muthukumaran J, Singh AK, Jain M (2023) Shedding light on structure, function and regulation of human sirtuins: a comprehensive review. 3 Biotech 13(1):29","journal-title":"3 Biotech"},{"key":"4486_CR13","doi-asserted-by":"publisher","first-page":"e81850","DOI":"10.7554\/eLife.81850","volume":"12","author":"J Xie","year":"2023","unstructured":"Xie J, Zhang W, Zhu X, Deng M, Lai L (2023) Coevolution-based prediction of key allosteric residues for protein function regulation. Elife. 12:e81850","journal-title":"Elife."},{"key":"4486_CR14","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s11064-016-1892-2","volume":"41","author":"J-Y Zhang","year":"2016","unstructured":"Zhang J-Y, Deng Y-N, Zhang M et al (2016) SIRT3 acts as a neuroprotective agent in rotenone-induced Parkinson cell model. Neurochem Res 41:1761\u20131773. https:\/\/doi.org\/10.1007\/s11064-016-1892-2","journal-title":"Neurochem Res"},{"key":"4486_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20120030","volume":"444","author":"A Giralt","year":"2012","unstructured":"Giralt A, Villarroya F (2012) SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J 444:1\u201310","journal-title":"Biochem J"},{"key":"4486_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11910-015-0545-1","volume":"15","author":"RM Guerriero","year":"2015","unstructured":"Guerriero RM, Giza CC, Rotenberg A (2015) Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep 15:27. https:\/\/doi.org\/10.1007\/s11910-015-0545-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4486_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3171\/jns.1998.89.4.0507","volume":"89","author":"R Bullock","year":"1998","unstructured":"Bullock R, Zauner A, Woodward JJ et al (1998) Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg 89:507\u2013518","journal-title":"J Neurosurg"},{"issue":"3","key":"4486_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.7150\/ijbs.89253","volume":"20","author":"Z Li","year":"2024","unstructured":"Li Z, Hu O, Xu S, Lin C, Yu W, Ma D, Lu J, Liu P (2024) The SIRT3-ATAD3A axis regulates MAM dynamics and mitochondrial calcium homeostasis in cardiac hypertrophy. Int J Biol Sci 20(3):831","journal-title":"Int J Biol Sci"},{"key":"4486_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0006-8993(01)02872-4","volume":"920","author":"A Wong","year":"2001","unstructured":"Wong A, L\u00fcth H-J, Deuther-Conrad W et al (2001) Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer\u2019s disease. Brain Res 920:32\u201340","journal-title":"Brain Res"},{"key":"4486_CR20","first-page":"376","volume":"7","author":"X Chen","year":"2012","unstructured":"Chen X, Guo C, Kong J (2012) Oxidative stress in neurodegenerative diseases. Neural Regen Res 7:376","journal-title":"Neural Regen Res"},{"key":"4486_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.23736\/S0031-0808.18.03462-6","volume":"60","author":"G Gupta","year":"2018","unstructured":"Gupta G, Singhvi G, Chellappan DK et al (2018) Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma. Panminerva Med 60:109\u201311","journal-title":"Panminerva Med"},{"key":"4486_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","volume":"30","author":"A Phaniendra","year":"2015","unstructured":"Phaniendra A, Jestadi DB, Periyasamy L (2015) Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem 30:11\u201326. https:\/\/doi.org\/10.1007\/s12291-014-0446-0","journal-title":"Indian J Clin Biochem"},{"key":"4486_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/0973-7847.70902","volume":"4","author":"V Lobo","year":"2010","unstructured":"Lobo V, Patil A, Phatak A, Chandra N (2010) Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev 4:118","journal-title":"Pharmacogn Rev"},{"key":"4486_CR24","doi-asserted-by":"publisher","first-page":"729757","DOI":"10.3389\/fnins.2021.729757","volume":"15","author":"F Franzoni","year":"2021","unstructured":"Franzoni F, Scarf\u00f2 G, Guidotti S et al (2021) Oxidative stress and cognitive decline: the neuroprotective role of natural antioxidants. Front Neurosci 15:729757","journal-title":"Front Neurosci"},{"key":"4486_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fnmol.2020.00041","volume":"13","author":"A Kandlur","year":"2020","unstructured":"Kandlur A, Satyamoorthy K, Gangadharan G (2020) Oxidative stress in cognitive and epigenetic aging: a retrospective glance. Front Mol Neurosci 13:41","journal-title":"Front Mol Neurosci"},{"key":"4486_CR26","first-page":"451","volume":"8","author":"ML Diaz-Hung","year":"2014","unstructured":"Diaz-Hung ML, Fraguela MG (2014) Oxidative stress in neurological diseases: cause or effect? Neurol Engl Ed 8:451\u2013452","journal-title":"Neurol Engl Ed"},{"key":"4486_CR27","doi-asserted-by":"publisher","first-page":"a011304","DOI":"10.1101\/cshperspect.a011304","volume":"5","author":"TL Schwarz","year":"2013","unstructured":"Schwarz TL (2013) Mitochondrial trafficking in neurons. Cold Spring Harb Perspect Biol 5:a011304","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4486_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1083\/jcb.201312123","volume":"204","author":"Z-H Sheng","year":"2014","unstructured":"Sheng Z-H (2014) Mitochondrial trafficking and anchoring in neurons: new insight and implications. J Cell Biol 204:1087\u20131098","journal-title":"J Cell Biol"},{"key":"4486_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","volume":"21","author":"M Giacomello","year":"2020","unstructured":"Giacomello M, Pyakurel A, Glytsou C, Scorrano L (2020) The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol 21:204\u2013224","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4486_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nn.2471","volume":"13","author":"JY Kim","year":"2010","unstructured":"Kim JY, Shen S, Dietz K et al (2010) HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci 13:180\u2013189","journal-title":"Nat Neurosci"},{"key":"4486_CR31","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.celrep.2017.10.060","volume":"21","author":"V Debattisti","year":"2017","unstructured":"Debattisti V, Gerencser AA, Saotome M et al (2017) ROS control mitochondrial motility through p38 and the motor adaptor Miro\/Trak. Cell Rep 21:1667\u20131680","journal-title":"Cell Rep"},{"key":"4486_CR32","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3390\/ijms21072346","volume":"21","author":"J Yue","year":"2020","unstructured":"Yue J, L\u00f3pez JM (2020) Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci 21:2346","journal-title":"Int J Mol Sci"},{"key":"4486_CR33","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3233\/JAD-160726","volume":"57","author":"Q Cai","year":"2017","unstructured":"Cai Q, Tammineni P (2017) Mitochondrial aspects of synaptic dysfunction in Alzheimer\u2019s disease. J Alzheimers Dis 57:1087\u20131103","journal-title":"J Alzheimers Dis"},{"key":"4486_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1242\/jcs.171017","volume":"130","author":"KH Flippo","year":"2017","unstructured":"Flippo KH, Strack S (2017) Mitochondrial dynamics in neuronal injury, development and plasticity. J Cell Sci 130:671\u2013681","journal-title":"J Cell Sci"},{"key":"4486_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-020-00107-x","volume":"5","author":"P Norat","year":"2020","unstructured":"Norat P, Soldozy S, Sokolowski JD et al (2020) Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation. NPJ Regen Med 5:22","journal-title":"NPJ Regen Med"},{"key":"4486_CR36","doi-asserted-by":"publisher","first-page":"eabj0722","DOI":"10.1126\/sciadv.abj0722","volume":"7","author":"O Antico","year":"2021","unstructured":"Antico O, Ordureau A, Stevens M et al (2021) Global ubiquitylation analysis of mitochondria in primary neurons identifies endogenous Parkin targets following activation of PINK1. Sci Adv 7:eabj0722. https:\/\/doi.org\/10.1126\/sciadv.abj0722","journal-title":"Sci Adv"},{"key":"4486_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","volume":"15","author":"P Ge","year":"2020","unstructured":"Ge P, Dawson VL, Dawson TM (2020) PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease. Mol Neurodegener 15:20. https:\/\/doi.org\/10.1186\/s13024-020-00367-7","journal-title":"Mol Neurodegener"},{"key":"4486_CR38","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1083\/jcb.200406038","volume":"167","author":"M Yi","year":"2004","unstructured":"Yi M, Weaver D, Hajn\u00f3czky G (2004) Control of mitochondrial motility and distribution by the calcium signal: a homeostatic circuit. J Cell Biol 167:661\u2013672","journal-title":"J Cell Biol"},{"key":"4486_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/978-3-030-41858-8_20","volume-title":"Nanoformulations in human health","author":"P Pandey","year":"2020","unstructured":"Pandey P, Mehta M, Shukla S et al (2020) Emerging nanotechnology in chronic respiratory diseases. In: Talegaonkar S, Rai M (eds) Nanoformulations in human health. Springer International Publishing, Cham, pp 449\u2013468"},{"key":"4486_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/157016312799304516","volume":"9","author":"M Rahman","year":"2012","unstructured":"Rahman M, Zaki Ahmad M, Kazmi I et al (2012) Insight into the biomarkers as the novel anti-psoriatic drug discovery tool: a contemporary viewpoint. Curr Drug Discov Technol 9:48\u201362","journal-title":"Curr Drug Discov Technol"},{"key":"4486_CR41","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3389\/fphys.2018.01094","volume":"9","author":"RM Parodi-Rull\u00e1n","year":"2018","unstructured":"Parodi-Rull\u00e1n RM, Chapa-Dubocq XR, Javadov S (2018) Acetylation of mitochondrial proteins in the heart: the role of SIRT3. Front Physiol 9:1094","journal-title":"Front Physiol"},{"issue":"11","key":"4486_CR42","first-page":"313","volume":"12","author":"H Meng","year":"2018","unstructured":"Meng H, Yan WY, Lei YH, Wan Z, Hou YY, Sun LK, Zhou JP (2018) SIRT3 regulation of mitochondrial quality control in neurodegenerative diseases. Front Aging Neurosci 12(11):313","journal-title":"Front Aging Neurosci"},{"key":"4486_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fnagi.2019.00313","volume":"11","author":"H Meng","year":"2019","unstructured":"Meng H, Yan W-Y, Lei Y-H et al (2019) SIRT3 regulation of mitochondrial quality control in neurodegenerative diseases. Front Aging Neurosci 11:313","journal-title":"Front Aging Neurosci"},{"key":"4486_CR44","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/ijms24021615","volume":"24","author":"A Tyagi","year":"2023","unstructured":"Tyagi A, Pugazhenthi S (2023) A promising strategy to treat neurodegenerative diseases by SIRT3 activation. Int J Mol Sci 24:1615","journal-title":"Int J Mol Sci"},{"key":"4486_CR45","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3892\/etm.2022.11598","volume":"24","author":"D-Q Jiang","year":"2022","unstructured":"Jiang D-Q, Zang Q-M, Jiang L-L et al (2022) SIRT3 expression alleviates microglia activation-induced dopaminergic neuron injury through the mitochondrial pathway. Exp Ther Med 24:662. https:\/\/doi.org\/10.3892\/etm.2022.11598","journal-title":"Exp Ther Med"},{"key":"4486_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cmet.2015.10.013","volume":"23","author":"A Cheng","year":"2016","unstructured":"Cheng A, Yang Y, Zhou Y et al (2016) Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges. Cell Metab 23:128\u2013142","journal-title":"Cell Metab"},{"key":"4486_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/ars.2017.7290","volume":"28","author":"CK Singh","year":"2018","unstructured":"Singh CK, Chhabra G, Ndiaye MA et al (2018) The role of sirtuins in antioxidant and redox signaling. Antioxid Redox Signal 28:643\u2013661. https:\/\/doi.org\/10.1089\/ars.2017.7290","journal-title":"Antioxid Redox Signal"},{"key":"4486_CR48","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.bbrc.2017.01.163","volume":"484","author":"X-X Cui","year":"2017","unstructured":"Cui X-X, Li X, Dong S-Y et al (2017) SIRT3 deacetylated and increased citrate synthase activity in PD model. Biochem Biophys Res Commun 484:767\u2013773","journal-title":"Biochem Biophys Res Commun"},{"key":"4486_CR49","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1471-4159.2011.07581.x","volume":"120","author":"B Sheng","year":"2012","unstructured":"Sheng B, Wang X, Su B et al (2012) Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer\u2019s disease. J Neurochem 120:419\u2013429. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07581.x","journal-title":"J Neurochem"},{"key":"4486_CR50","doi-asserted-by":"publisher","first-page":"24460","DOI":"10.1074\/jbc.M112.382226","volume":"287","author":"J Fu","year":"2012","unstructured":"Fu J, Jin J, Cichewicz RH et al (2012) trans-(-)-\u03b5-viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington disease. J Biol Chem 287:24460\u201324472","journal-title":"J Biol Chem"},{"key":"4486_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.febslet.2007.11.034","volume":"582","author":"JT Rodgers","year":"2008","unstructured":"Rodgers JT, Lerin C, Gerhart-Hines Z, Puigserver P (2008) Metabolic adaptations through the PGC-1\u03b1 and SIRT1 pathways. FEBS Lett 582:46\u201353","journal-title":"FEBS Lett"},{"key":"4486_CR52","doi-asserted-by":"publisher","first-page":"884S","DOI":"10.3945\/ajcn.110.001917","volume":"93","author":"PJ Fernandez-Marcos","year":"2011","unstructured":"Fernandez-Marcos PJ, Auwerx J (2011) Regulation of PGC-1\u03b1, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 93:884S-890S","journal-title":"Am J Clin Nutr"},{"key":"4486_CR53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","volume":"20","author":"C Cant\u00f3","year":"2009","unstructured":"Cant\u00f3 C, Auwerx J (2009) PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 20:98","journal-title":"Curr Opin Lipidol"},{"key":"4486_CR54","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s42003-021-02498-z","volume":"4","author":"Y Matsushima","year":"2021","unstructured":"Matsushima Y, Takahashi K, Yue S et al (2021) Mitochondrial Lon protease is a gatekeeper for proteins newly imported into the matrix. Commun Biol 4:974","journal-title":"Commun Biol"},{"key":"4486_CR55","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.freeradbiomed.2016.06.031","volume":"100","author":"DA Bota","year":"2016","unstructured":"Bota DA, Davies KJ (2016) Mitochondrial Lon protease in human disease and aging: Including an etiologic classification of Lon-related diseases and disorders. Free Radic Biol Med 100:188\u2013198","journal-title":"Free Radic Biol Med"},{"key":"4486_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/biom10020253","volume":"10","author":"W Voos","year":"2020","unstructured":"Voos W, Pollecker K (2020) The mitochondrial Lon protease: novel functions off the beaten track? Biomolecules 10:253","journal-title":"Biomolecules"},{"key":"4486_CR57","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0349-x","volume":"15","author":"J-H Park","year":"2020","unstructured":"Park J-H, Burgess JD, Faroqi AH et al (2020) Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway. Mol Neurodegener 15:5. https:\/\/doi.org\/10.1186\/s13024-019-0349-x","journal-title":"Mol Neurodegener"},{"key":"4486_CR58","doi-asserted-by":"publisher","first-page":"845330","DOI":"10.3389\/fnagi.2022.845330","volume":"14","author":"W Wan","year":"2022","unstructured":"Wan W, Hua F, Fang P et al (2022) Regulation of mitophagy by sirtuin family proteins: a vital role in aging and age-related diseases. Front Aging Neurosci 14:845330","journal-title":"Front Aging Neurosci"},{"key":"4486_CR59","first-page":"130","volume":"1","author":"J Adams","year":"2008","unstructured":"Adams J (2008) Genetic control of aging and life span. Nat Educ 1:130","journal-title":"Nat Educ"},{"issue":"6","key":"4486_CR60","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s11064-022-03560-w","volume":"47","author":"L He","year":"2022","unstructured":"He L, Wang J, Yang Y, Li J, Tu H (2022) Mitochondrial sirtuins in Parkinson\u2019s disease. Neurochem Res 47(6):1491\u2013502","journal-title":"Neurochem Res"},{"key":"4486_CR61","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.cell.2005.08.042","volume":"123","author":"P Fabrizio","year":"2005","unstructured":"Fabrizio P, Gattazzo C, Battistella L et al (2005) Sir2 blocks extreme life-span extension. Cell 123:655\u2013667","journal-title":"Cell"},{"key":"4486_CR62","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3389\/fnins.2018.00799","volume":"12","author":"JM Marcus","year":"2018","unstructured":"Marcus JM, Andrabi SA (2018) SIRT3 regulation under cellular stress: making sense of the ups and downs. Front Neurosci 12:799","journal-title":"Front Neurosci"},{"key":"4486_CR63","doi-asserted-by":"publisher","unstructured":"Weinert BT, Moustafa T, Iesmantavicius V, et al (2015) Analysis of acetylation stoichiometry suggests that SIRT repairs nonenzymatic acetylation lesions. EMBO J 34:2620\u20132632. https:\/\/doi.org\/10.15252\/embj.201591271","DOI":"10.15252\/embj.201591271"},{"key":"4486_CR64","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41419-021-04134-4","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wen P, Luo J et al (2021) Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis. Cell Death Dis 12:847","journal-title":"Cell Death Dis"},{"key":"4486_CR65","doi-asserted-by":"publisher","first-page":"14118","DOI":"10.1096\/fj.201900708R","volume":"33","author":"L Tu","year":"2019","unstructured":"Tu L, Cao L, Zhang Y et al (2019) Sirt3-dependent deacetylation of COX-1 counteracts oxidative stress-induced cell apoptosis. FASEB J 33:14118\u201314128. https:\/\/doi.org\/10.1096\/fj.201900708R","journal-title":"FASEB J"},{"key":"4486_CR66","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.tem.2015.06.001","volume":"26","author":"E McDonnell","year":"2015","unstructured":"McDonnell E, Peterson BS, Bomze HM, Hirschey MD (2015) SIRT3 regulates progression and development of diseases of aging. Trends Endocrinol Metab 26:486\u2013492","journal-title":"Trends Endocrinol Metab"},{"key":"4486_CR67","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","volume":"46","author":"MC White","year":"2014","unstructured":"White MC, Holman DM, Boehm JE et al (2014) Age and cancer risk: a potentially modifiable relationship. Am J Prev Med 46:S7\u2013S15","journal-title":"Am J Prev Med"},{"key":"4486_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/MAJ.0000000000000281","volume":"348","author":"JP Thakkar","year":"2014","unstructured":"Thakkar JP, Villano JL, McCarthy BJ (2014) Age-specific cancer incidence rates increase through the oldest age groups. Am J Med Sci 348:65\u201370","journal-title":"Am J Med Sci"},{"key":"4486_CR69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0027-5107(01)00091-4","volume":"477","author":"AL Jackson","year":"2001","unstructured":"Jackson AL, Loeb LA (2001) The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res Mol Mech Mutagen 477:7\u201321","journal-title":"Mutat Res Mol Mech Mutagen"},{"key":"4486_CR70","first-page":"1","volume":"41","author":"N Parsa","year":"2012","unstructured":"Parsa N (2012) Environmental factors inducing human cancers. Iran J Public Health 41:1","journal-title":"Iran J Public Health"},{"key":"4486_CR71","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ccr.2009.11.023","volume":"17","author":"H-S Kim","year":"2010","unstructured":"Kim H-S, Patel K, Muldoon-Jacobs K et al (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17:41\u201352","journal-title":"Cancer Cell"},{"key":"4486_CR72","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12885-020-06822-4","volume":"20","author":"H Jo","year":"2020","unstructured":"Jo H, Park Y, Kim T et al (2020) Modulation of SIRT3 expression through CDK4\/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells. BMC Cancer 20:332. https:\/\/doi.org\/10.1186\/s12885-020-06822-4","journal-title":"BMC Cancer"},{"key":"4486_CR73","doi-asserted-by":"publisher","first-page":"910963","DOI":"10.3389\/fonc.2022.910963","volume":"12","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Zhou J, Li F et al (2022) The role and therapeutic perspectives of SIRTuin 3 in cancer metabolism reprogramming, metastasis, and chemoresistance. Front Oncol 12:910963","journal-title":"Front Oncol"},{"key":"4486_CR74","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ccr.2011.02.014","volume":"19","author":"LW Finley","year":"2011","unstructured":"Finley LW, Carracedo A, Lee J et al (2011) SIRT3 opposes reprogramming of cancer cell metabolism through HIF1\u03b1 destabilization. Cancer Cell 19:416\u2013428","journal-title":"Cancer Cell"},{"key":"4486_CR75","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12967-023-03925-x","volume":"21","author":"L Wu","year":"2023","unstructured":"Wu L, Yan X, Sun R et al (2023) Sirt3 restricts tumor initiation via promoting LONP1 deacetylation and K63 ubiquitination. J Transl Med 21:81. https:\/\/doi.org\/10.1186\/s12967-023-03925-x","journal-title":"J Transl Med"},{"key":"4486_CR76","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"4486_CR77","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3892\/ijo.2016.3767","volume":"49","author":"Y Xiong","year":"2016","unstructured":"Xiong Y, Wang M, Zhao J et al (2016) Sirtuin 3: a Janus face in cancer (Review). Int J Oncol 49:2227\u20132235. https:\/\/doi.org\/10.3892\/ijo.2016.3767","journal-title":"Int J Oncol"},{"key":"4486_CR78","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13046-016-0461-5","volume":"35","author":"Z Mei","year":"2016","unstructured":"Mei Z, Zhang X, Yi J et al (2016) Sirtuins in metabolism, DNA repair and cancer. J Exp Clin Cancer Res 35:182. https:\/\/doi.org\/10.1186\/s13046-016-0461-5","journal-title":"J Exp Clin Cancer Res"},{"key":"4486_CR79","doi-asserted-by":"publisher","first-page":"626577","DOI":"10.3389\/fonc.2021.626577","volume":"11","author":"FO Adeshakin","year":"2021","unstructured":"Adeshakin FO, Adeshakin AO, Afolabi LO et al (2021) Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming. Front Oncol 11:626577","journal-title":"Front Oncol"},{"key":"4486_CR80","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:619\u2013626","journal-title":"J Cell Biol"},{"key":"4486_CR81","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12964-023-01247-5","volume":"21","author":"Y-H Han","year":"2023","unstructured":"Han Y-H, Wang Y, Lee S-J et al (2023) Regulation of anoikis by extrinsic death receptor pathways. Cell Commun Signal 21:227. https:\/\/doi.org\/10.1186\/s12964-023-01247-5","journal-title":"Cell Commun Signal"},{"key":"4486_CR82","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1091\/mbc.e09-06-0530","volume":"21","author":"P Kamarajan","year":"2010","unstructured":"Kamarajan P, Bunek J, Lin Y et al (2010) Receptor-interacting protein shuttles between cell death and survival signaling pathways. Mol Biol Cell 21:481\u2013488. https:\/\/doi.org\/10.1091\/mbc.e09-06-0530","journal-title":"Mol Biol Cell"},{"key":"4486_CR83","first-page":"400","volume":"25","author":"DW Kamp","year":"2011","unstructured":"Kamp DW, Weitzman SA (2011) Chronic inflammation and cancer: the role of the mitochondria. Oncology 25:400","journal-title":"Oncology"},{"issue":"23","key":"4486_CR84","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1002\/cncr.27655","volume":"118","author":"P Kamarajan","year":"2012","unstructured":"Kamarajan P, Alhazzazi TY, Danciu T, D\u2019silva NJ, Verdin E, Kapila YL (2012) Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis. Cancer 118(23):5800\u201310","journal-title":"Cancer"},{"key":"4486_CR85","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.freeradbiomed.2011.05.028","volume":"51","author":"T Koyama","year":"2011","unstructured":"Koyama T, Kume S, Koya D et al (2011) SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells. Free Radic Biol Med 51:1258\u20131267","journal-title":"Free Radic Biol Med"},{"key":"4486_CR86","unstructured":"Fountain JH, Kaur J, Lappin SL (2023) Physiology, renin angiotensin system. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL, USA"},{"key":"4486_CR87","doi-asserted-by":"publisher","unstructured":"Kurundkar D, Kurundkar AR, Bone NB, et al (2019) SIRT3 diminishes inflammation and mitigates endotoxin-induced acute lung injury. JCI Insight 4. https:\/\/doi.org\/10.1172\/jci.insight.120722","DOI":"10.1172\/jci.insight.120722"},{"key":"4486_CR88","doi-asserted-by":"publisher","first-page":"953078","DOI":"10.3389\/fphys.2022.953078","volume":"13","author":"Z Pan","year":"2022","unstructured":"Pan Z, Dong H, Huang N, Fang J (2022) Oxidative stress and inflammation regulation of sirtuins: new insights into common oral diseases. Front Physiol 13:953078","journal-title":"Front Physiol"},{"key":"4486_CR89","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/aac2.12035","volume":"2","author":"EC Jenkins","year":"2021","unstructured":"Jenkins EC, Chattopadhyay M, Germain D (2021) Are the estrogen receptor and SIRT3 axes of the mitochondrial UPR key regulators of breast cancer subtype determination according to age? Aging Cancer 2:75\u201381. https:\/\/doi.org\/10.1002\/aac2.12035","journal-title":"Aging Cancer"},{"key":"4486_CR90","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-11-3633","volume":"72","author":"MC Haigis","year":"2012","unstructured":"Haigis MC, Deng C-X, Finley LW et al (2012) SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis. Cancer Res 72:2468\u20132472","journal-title":"Cancer Res"},{"key":"4486_CR91","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.molmed.2012.05.004","volume":"18","author":"LW Finley","year":"2012","unstructured":"Finley LW, Haigis MC (2012) Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol Med 18:516\u2013523","journal-title":"Trends Mol Med"},{"key":"4486_CR92","doi-asserted-by":"publisher","unstructured":"Sun W, Liu C, Chen Q et al (2018) SIRT3: a new regulator of cardiovascular diseases. Oxid Med Cell Longev 2018.\u00a0https:\/\/doi.org\/10.1155\/2018\/7293861","DOI":"10.1155\/2018\/7293861"},{"key":"4486_CR93","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ijcard.2016.06.236","volume":"220","author":"Y Lu","year":"2016","unstructured":"Lu Y, Wang Y, Wang X et al (2016) SIRT3 in cardiovascular diseases: emerging roles and therapeutic implications. Int J Cardiol 220:700\u2013705","journal-title":"Int J Cardiol"},{"key":"4486_CR94","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5114\/pm.2017.68589","volume":"16","author":"K Mordarska","year":"2017","unstructured":"Mordarska K, Godziejewska-Zawada M (2017) Diabetes in the elderly. Menopause Rev Menopauzalny 16:38\u201343","journal-title":"Menopause Rev Menopauzalny"},{"key":"4486_CR95","doi-asserted-by":"crossref","unstructured":"Laiteerapong N, Huang ES (2018) Diabetes in older adults. Diabetes Am\u00a035(12):2650\u20132664","DOI":"10.2337\/dc12-1801"},{"issue":"15","key":"4486_CR96","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.3390\/ijms21155266","volume":"21","author":"CH Wang","year":"2020","unstructured":"Wang CH, Wei YH (2020) Roles of mitochondrial sirtuins in mitochondrial function, redox homeostasis, insulin resistance and type 2 diabetes. Int J Molecular Sci 21(15):5266","journal-title":"Int J Molecular Sci"},{"key":"4486_CR97","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/ars.2009.2531","volume":"12","author":"WI Sivitz","year":"2010","unstructured":"Sivitz WI, Yorek MA (2010) Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal 12:537\u2013577. https:\/\/doi.org\/10.1089\/ars.2009.2531","journal-title":"Antioxid Redox Signal"},{"key":"4486_CR98","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fphys.2019.00532","volume":"10","author":"D Sergi","year":"2019","unstructured":"Sergi D, Naumovski N, Heilbronn LK et al (2019) Mitochondrial (dys) function and insulin resistance: from pathophysiological molecular mechanisms to the impact of diet. Front Physiol 10:532","journal-title":"Front Physiol"},{"key":"4486_CR99","doi-asserted-by":"publisher","first-page":"165838","DOI":"10.1016\/j.bbadis.2020.165838","volume":"1866","author":"P Prasun","year":"2020","unstructured":"Prasun P (2020) Mitochondrial dysfunction in metabolic syndrome. Biochim Biophys Acta BBA-Mol Basis Dis 1866:165838","journal-title":"Biochim Biophys Acta BBA-Mol Basis Dis"},{"key":"4486_CR100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12964-020-00640-8","volume":"18","author":"E Barroso Fern\u00e1ndez","year":"2020","unstructured":"Barroso Fern\u00e1ndez E, Rodr\u00edguez-Rodr\u00edguez R, Zarei M et al (2020) SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1\u03b1-LIPIN 1 pathway and increasing CD36 through Nrf2. Cell Common Signal 18:147","journal-title":"Cell Common Signal"},{"key":"4486_CR101","doi-asserted-by":"publisher","unstructured":"Sun W, Liu C, Chen Q, Liu N, Yan Y, Liu B (2018) SIRT3: a new regulator of cardiovascular diseases. Oxid Med Cell Longev.\u00a0https:\/\/doi.org\/10.1155\/2018\/7293861","DOI":"10.1155\/2018\/7293861"},{"key":"4486_CR102","doi-asserted-by":"publisher","first-page":"17312","DOI":"10.1074\/jbc.M117.778720","volume":"292","author":"S Kwon","year":"2017","unstructured":"Kwon S, Seok S, Yau P et al (2017) Obesity and aging diminish sirtuin 1 (SIRT1)-mediated deacetylation of SIRT3, leading to hyperacetylation and decreased activity and stability of SIRT3. J Biol Chem 292:17312\u201317323","journal-title":"J Biol Chem"},{"key":"4486_CR103","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.2337\/db12-1650","volume":"62","author":"E Jing","year":"2013","unstructured":"Jing E, O\u2019Neill BT, Rardin MJ et al (2013) Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 62:3404\u20133417","journal-title":"Diabetes"},{"key":"4486_CR104","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.2337\/db14-1810","volume":"64","author":"L Lantier","year":"2015","unstructured":"Lantier L, Williams AS, Williams IM et al (2015) SIRT3 is crucial for maintaining skeletal muscle insulin action and protects against severe insulin resistance in high-fat\u2013fed mice. Diabetes 64:3081\u20133092","journal-title":"Diabetes"},{"key":"4486_CR105","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.2337\/db13-1845","volume":"63","author":"L Kang","year":"2014","unstructured":"Kang L, Dai C, Lustig ME et al (2014) Heterozygous SOD2 deletion impairs glucose-stimulated insulin secretion, but not insulin action, in high-fat\u2013fed mice. Diabetes 63:3699\u20133710","journal-title":"Diabetes"},{"key":"4486_CR106","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fendo.2013.00037","volume":"4","author":"ME Cerf","year":"2013","unstructured":"Cerf ME (2013) Beta cell dysfunction and insulin resistance. Front Endocrinol 4:37","journal-title":"Front Endocrinol"},{"key":"4486_CR107","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1210\/jc.2014-1425","volume":"99","author":"PA Halban","year":"2014","unstructured":"Halban PA, Polonsky KS, Bowden DW et al (2014) \u03b2-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. J Clin Endocrinol Metab 99:1983\u20131992","journal-title":"J Clin Endocrinol Metab"},{"key":"4486_CR108","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1111\/jdi.13576","volume":"12","author":"H Ikegami","year":"2021","unstructured":"Ikegami H, Babaya N, Noso S (2021) \u03b2-cell failure in diabetes: common susceptibility and mechanisms shared between type 1 and type 2 diabetes. J Diabetes Investig 12:1526\u20131539. https:\/\/doi.org\/10.1111\/jdi.13576","journal-title":"J Diabetes Investig"},{"key":"4486_CR109","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.celrep.2018.05.088","volume":"24","author":"BS Peterson","year":"2018","unstructured":"Peterson BS, Campbell JE, Ilkayeva O et al (2018) Remodeling of the acetylproteome by SIRT3 manipulation fails to affect insulin secretion or \u03b2 cell metabolism in the absence of overnutrition. Cell Rep 24:209\u2013223","journal-title":"Cell Rep"},{"key":"4486_CR110","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1007\/s00125-013-2851-y","volume":"56","author":"PW Caton","year":"2013","unstructured":"Caton PW, Richardson SJ, Kieswich J et al (2013) Sirtuin 3 regulates mouse pancreatic beta cell function and is suppressed in pancreatic islets isolated from human type 2 diabetic patients. Diabetologia 56:1068\u20131077","journal-title":"Diabetologia"},{"key":"4486_CR111","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41392-020-0114-1","volume":"5","author":"X Palomer","year":"2020","unstructured":"Palomer X, Rom\u00e1n-Azcona MS, Pizarro-Delgado J et al (2020) SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation. Signal Transduct Target Ther 5:14","journal-title":"Signal Transduct Target Ther"},{"key":"4486_CR112","doi-asserted-by":"publisher","first-page":"914","DOI":"10.18632\/aging.100252","volume":"2","author":"AV Hafner","year":"2010","unstructured":"Hafner AV, Dai J, Gomes AP et al (2010) Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging 2:914","journal-title":"Aging"},{"key":"4486_CR113","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1111\/jcmm.12556","volume":"19","author":"H Zeng","year":"2015","unstructured":"Zeng H, Vaka VR, He X et al (2015) High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT 3 loss. J Cell Mol Med 19:1847\u20131856. https:\/\/doi.org\/10.1111\/jcmm.12556","journal-title":"J Cell Mol Med"},{"key":"4486_CR114","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00395-015-0493-6","volume":"110","author":"C Koentges","year":"2015","unstructured":"Koentges C, Pfeil K, Schnick T et al (2015) SIRT3 deficiency impairs mitochondrial and contractile function in the heart. Basic Res Cardiol 110:36. https:\/\/doi.org\/10.1007\/s00395-015-0493-6","journal-title":"Basic Res Cardiol"},{"key":"4486_CR115","doi-asserted-by":"publisher","first-page":"e0118909","DOI":"10.1371\/journal.pone.0118909","volume":"10","author":"T Chen","year":"2015","unstructured":"Chen T, Liu J, Li NA et al (2015) Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD. PloS One 10:e0118909","journal-title":"PloS One"},{"key":"4486_CR116","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.freeradbiomed.2010.07.009","volume":"49","author":"J Bao","year":"2010","unstructured":"Bao J, Scott I, Lu Z et al (2010) SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic Biol Med 49:1230\u20131237","journal-title":"Free Radic Biol Med"},{"key":"4486_CR117","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1161\/CIRCULATIONAHA.105.550806","volume":"112","author":"F Ahmad","year":"2005","unstructured":"Ahmad F, Arad M, Musi N et al (2005) Increased \u03b12 subunit\u2013associated AMPK activity and PRKAG2 cardiomyopathy. Circulation 112:3140\u20133148. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.550806","journal-title":"Circulation"},{"key":"4486_CR118","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/hrt.2005.068270","volume":"93","author":"M Seddon","year":"2007","unstructured":"Seddon M, Looi YH, Shah AM (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93:903\u2013907","journal-title":"Heart"},{"key":"4486_CR119","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","volume":"49","author":"E Takimoto","year":"2007","unstructured":"Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49:241\u2013248. https:\/\/doi.org\/10.1161\/01.HYP.0000254415.31362.a7","journal-title":"Hypertension"},{"key":"4486_CR120","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.3390\/ijms24043162","volume":"24","author":"M Ponzoni","year":"2023","unstructured":"Ponzoni M, Coles JG, Maynes JT (2023) Rodent models of dilated cardiomyopathy and heart failure for translational investigations and therapeutic discovery. Int J Mol Sci 24:3162","journal-title":"Int J Mol Sci"},{"key":"4486_CR121","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1242\/jcs.061846","volume":"123","author":"N Shulga","year":"2010","unstructured":"Shulga N, Wilson-Smith R, Pastorino JG (2010) Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria. J Cell Sci 123:894\u2013902","journal-title":"J Cell Sci"},{"key":"4486_CR122","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1242\/jcs.193631","volume":"129","author":"N Shulga","year":"2016","unstructured":"Shulga N, Wilson-Smith R, Pastorino JG (2016) Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria. J Cell Sci 129:2684","journal-title":"J Cell Sci"},{"key":"4486_CR123","doi-asserted-by":"publisher","first-page":"e01612","DOI":"10.7554\/eLife.01612","volume":"3","author":"K Yamano","year":"2014","unstructured":"Yamano K, Fogel AI, Wang C et al (2014) Mitochondrial Rab GAPs govern autophagosome biogenesis during mitophagy. Elife 3:e01612","journal-title":"Elife"},{"key":"4486_CR124","doi-asserted-by":"publisher","unstructured":"Murata D, Yamada T, Tokuyama T, et al (2020) Mitochondrial Safeguard: a stress response that offsets extreme fusion and protects respiratory function via flickering\u2010induced Oma1 activation. EMBO J 39:e105074. https:\/\/doi.org\/10.15252\/embj.2020105074","DOI":"10.15252\/embj.2020105074"},{"key":"4486_CR125","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1128\/MCB.01483-13","volume":"34","author":"SA Samant","year":"2014","unstructured":"Samant SA, Zhang HJ, Hong Z et al (2014) SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Mol Cell Biol 34:807\u2013819. https:\/\/doi.org\/10.1128\/MCB.01483-13","journal-title":"Mol Cell Biol"},{"key":"4486_CR126","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.120.317293","volume":"127","author":"MT Davidson","year":"2020","unstructured":"Davidson MT, Grimsrud PA, Lai L et al (2020) Extreme acetylation of the cardiac mitochondrial proteome does not promote heart failure. Circ Res 127:1094\u20131108. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317293","journal-title":"Circ Res"},{"key":"4486_CR127","doi-asserted-by":"publisher","first-page":"1133611","DOI":"10.3389\/fcvm.2023.1133611","volume":"10","author":"M Funamoto","year":"2023","unstructured":"Funamoto M, Imanishi M, Tsuchiya K, Ikeda Y (2023) Roles of histone acetylation sites in cardiac hypertrophy and heart failure. Front Cardiovasc Med 10:1133611","journal-title":"Front Cardiovasc Med"},{"key":"4486_CR128","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/1947601913486351","volume":"4","author":"TY Alhazzazi","year":"2013","unstructured":"Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL (2013) Sirtuin-3 (SIRT3) and the hallmarks of cancer. Genes Cancer 4:164\u2013171. https:\/\/doi.org\/10.1177\/1947601913486351","journal-title":"Genes Cancer"},{"key":"4486_CR129","doi-asserted-by":"publisher","first-page":"871560","DOI":"10.3389\/fphar.2022.871560","volume":"13","author":"S Ouyang","year":"2022","unstructured":"Ouyang S, Zhang Q, Lou L et al (2022) The double-edged sword of SIRT3 in cancer and its therapeutic applications. Front Pharmacol 13:871560","journal-title":"Front Pharmacol"},{"key":"4486_CR130","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.molcel.2011.07.019","volume":"44","author":"MD Hirschey","year":"2011","unstructured":"Hirschey MD, Shimazu T, Jing E et al (2011) SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 44:177\u2013190","journal-title":"Mol Cell"},{"key":"4486_CR131","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/biomedicines9111574","volume":"9","author":"CN Silaghi","year":"2021","unstructured":"Silaghi CN, Farca\u0219 M, Cr\u0103ciun AM (2021) Sirtuin 3 (SIRT3) pathways in age-related cardiovascular and neurodegenerative diseases. Biomedicines 9:1574","journal-title":"Biomedicines"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04486-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04486-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04486-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:02:23Z","timestamp":1747180943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04486-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":131,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4486"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04486-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}